IP Library Assignment 030098/0596
Patent Assignment
Reel/Frame 030098/0596

Assignment of Assignor's Interest

Recorded: 2013-03-27 Pages: 4
Assignors
RABELINK, TON J.
Executed: 2000-08-07
MOSER, RUDOLF
Executed: 2000-08-11
Assignee
EPROV A.G.
IM LATERNENACKER 5, SCHAFFHAUSEN, CH-8200, SWITZERLAND
Covered Property (1)
Pharmaceutical Preparation Containing at Least Folic Acid or a Folate and Tetrahydrobiopterin (BH4) or Derivatives Thereof Used for the Treating or Preventing Cardiovascular or Neurological Disorders by Modulation of the Activity of Nitric Oxide Synthase (Nos)
Patent: 6,995,158 →
Application: 10/377,618 →
Publication: US 2003/0216400
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Mar 28, 2013
From: EPROVA A.G.
To: MERCK EPROVA AG
Reel/Frame 030102/0592 →
Merger Mar 28, 2013
From: MERCK EPROVA AG
To: MERCK & CIE KG
Reel/Frame 030102/0669 →
Change of Name Mar 28, 2013
From: MERCK & CIE KG
To: MERCK & CIE
Reel/Frame 030102/0827 →
Corrective Assignment to Correct the Assignee Name Should Read: Eprova a.G. Previously Recorded on Reel 030098 Frame 0596. Assignor(S) Hereby Confirms the Assignee Name Eprov a.G. Contained a Spelling Error and Should Be Corrected to Read Eprova A.G.. Mar 29, 2013
From: RABELINK, TON J.; MOSER, RUDOLF
To: EPROVA A.G.
Reel/Frame 030111/0799 →